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Abstract
Background: Anemia is common in diabetic patients and increases morbidity and mortality, but its burden has
been less well characterized in sub-Saharan Africans. We determined the prevalence of anemia and investigated the
related factors, with a particular focus on the role of declining renal function, in type 2 diabetic patients attending a
tertiary health care institution in Cameroon.
Methods: Hemoglobin (Hb) levels were measured in a consecutive sample of patients with type 2 diabetes, who
reported for annual review at the outpatient section of the Douala General Hospital in 2013. Patients were classified
as anemic according to the World Health Organisation criteria (Hb < 12 g/dl for females and Hb < 13 g/dl for
males). Estimated glomerular filtration rate (eGFR) was calculated using the abbreviated Modification of Diet in
Renal Disease Study Group formula. Determinants of Hb concentration and anemia were investigated using
multivariable logistic regressions.
Results: A total of 636 patients were examined including 263 (prevalence rate 41.4 %) who had anemia. The
prevalence of anemia increased significantly with deteriorating kidney function, although up to 31.9 % of patients
with normal kidney function had anemia. Compared with their non-anemic counterparts, anemic diabetic patients
were older, had longer duration of diabetes, lower eGFR, higher prevalence of proteinuria and diabetic retinopathy
(all p < 0.05). In multivariable logistic regressions, eGFR (p = 0.001) and presence of retinopathy (p = 0.023) were the
independent determinants of prevalent anemia.
Conclusions: The prevalence of anemia is high in type 2 diabetic patients attending referral institutions in
Cameroon, including among those without chronic kidney disease. Routine screening for anemia in all diabetic
patients may aid early identification and correction as appropriate.
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Background
Developing countries are experiencing an upsurge in the
prevalence of diabetes [1], which is associated with a
high risk of microvascular complications [2]. For in-
stance, the prevalence of diabetes in Cameroon has risen
from 1.1 % in 1997 [3] to 5.9 % in 2013 [1]. It is ex-
pected that the prevalence of long-term complications of
diabetes will increase accordingly due to low awareness
of the disease [1] and suboptimal management of those
with diagnosed diabetes [4]. Among the chronic micro-
vascular diabetes complications, diabetic nephropathy
may present with anemia at different stages of deteri-
oration of the kidney function [5]. Accordingly, anemia
is a common feature in diabetes, with a reported
prevalence of 13 % in a European population [6], 23 %
in an Australian population [7] and up to 46.5 % in a
Caribbean population [8].
Chronic kidney disease (CKD) does not explain all
cases of anemia in diabetes, which seems to result from
an interplay between several factors that include: declin-
ing kidney function, functional erythropoietin deficiency,
nutritional deficiencies, chronic inflammation, iatrogenic
causes, and infectious diseases [9]. As a consequence,
anemia tends to occur early in diabetic patients, even in
the absence of overt nephropathy, and it is more severe
[10]. This is largely unrecognized by both physicians
and patients despite the fact that anemia negatively af-
fects the quality of life of diabetic patients [11]. Anemia
is also a significant adverse prognostic factor for cardio-
vascular disease, and all-cause mortality in people with
diabetes [12]. Early identification and correction of
anemia has been shown to reduce the rate of progres-
sion and even delay the onset of some microvascular
complications [13] as well as improve the quality of life
of diabetic patients [14].
Current guidelines on the management of diabetes do
not recommend routine screening for anemia. Although
reports on the prevalence and predictors of anemia in dia-
betic patients exists elsewhere, such information is very
rare in sub-Saharan Africa where other potential contribu-
tory factors like infectious and genetic diseases as well as
nutritional deficiencies are very frequent and likely to
worsen the burden of anemia. This study aimed to assess
the prevalence and investigate the role of kidney function
deterioration and other predictors of anemia in a popula-
tion of type 2 diabetic patients in Cameroon.
Methods
Study design, setting and population
We conducted a cross-sectional study involving all
consenting patients who were receiving chronic care
for type 2 diabetes at the out-patient section of the
endocrine unit of the Douala General Hospital (DGH),
and covered a period of activity of 6 months from 1st
June to 31st December 2013. DGH is a tertiary care
hospital located in Douala, the economic Capital of
Cameroon (approximately 2.8 million inhabitants) [15].
The endocrine unit of DGH is the main referral centre for
endocrine diseases and diabetes in Douala. Patients with
diabetes residing in Douala and surrounding regions were
likely to receive care in this unit during the study period.
Patients with diabetes receiving care in the unit undergo
an annual evaluation that includes amongst others: a clin-
ical evaluation, an assessment of diabetes control (HbA1c
level), chronic complications (fundoscopy, retinography
and retinal angiography where needed; dipstick protein-
uria and serum creatinine), and cardiovascular risk factors
assessment. The study received ethical approval from
the Institutional review board of the Faculty of Health
Sciences, University of Buea, and administrative clear-
ance from the authorities of the DGH. Patients with di-
agnosed type 2 diabetes, irrespective of gender and
aged 20 years or above, were included. All patients with
a known hematologic disease, any acute condition, or
those who received a blood transfusion in the preceding
4 months were excluded.
Data collection and laboratory procedures
For each consenting patient, data were collected on
medical and family history, and behavioral factors
(smoking, physical exercise and alcohol consumption).
The weight, height, blood pressure, waist and hip circum-
ferences were measured using standardized methods.
The body mass index (BMI) was calculated as weight
(in kilograms)/height × height (in meters).
The hemoglobin level was obtained from the full blood
count performed by an automated analyser (Ruby Cell
Dyn®, Abbott). The Jaffe method was used to measure
serum creatinine levels using a Roche – Hitachi Cobas
C311® analyser. Standard laboratory procedures were
used in the measurement of HbA1c (immuno-turbidi-
metric method) and lipid profile (enzymatic method).
Proteinuria was determined by dipstick.
Definitions
Patients were classified as anemic according to the
World Health Organization (WHO) criteria (Hb < 12 g/
dl for females and <13 g/dl for males) [16]. A second
definition of anemia was also used based on the sug-
gested threshold of Hb < 11 g⁄dl (for both sexes) for the
initiation of treatment with erythropoietin for anemia
in chronic kidney disease [17]. Based on mean corpus-
cular volume (MCV), anemia was classified as micro-
cytic (MCV < 80 fl), normocytic (MCV between 80 and
100 fl) or macrocytic (MCV > 100 fl). Mean corpuscular
hemoglobin concentration (MCHC) was used to
characterize anemia as hypochromic (MCHC <32 g/dl), or
normochromic (MCHC ≥32 g/dl). Estimated glomerular
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filtration rate (eGFR) (ml/min/1.73 m2) was calculated
using the abbreviated Modification of Diet in Renal Dis-
ease (MDRD) Study Group formula as eGFR =186 ×
[serum creatinine (mg/l)]−1.154 × [age (years)]−0.203 ×
0.192 × (0.742 for female) [18]. Based on eGFR (ml/min/
1.73 m2), patients were further classified into the five
stages of chronic kidney disease (CKD) as follows: stage 1
(eGFR ≥90); stage 2 (eGFR between 60 and 89); stage 3
(eGFR between 30 and 59); stage 4 (eGFR between 15 and
29) and stage 5 (eGFR <15) [17, 18].
Statistical analysis
Data were analyzed using SAS/STAT v.9.1 for Windows®
(SAS Institute Inc., Cary, NC, USA). We used the chi
squared test for comparison of categorical variables, and
the Student t-test or Kruskal-Wallis test for continuous
variables. Results are presented as count (percentages),
mean and standard deviation (SD) or median and 25th-
75thpercentiles as appropriate. Pearson correlation was
used to assess univariate associations between continu-
ous variables. Multivariable logistic regressions were
used to identify determinants of anemia; odd ratio
(OR) with 95 % confidence intervals (CI) are pre-
sented. A p-value <0.05 was used to characterize statis-
tically significant results.
Sample size estimation
The sample size was estimated assuming a prevalence of
anemia of 40 % based on a previous study in people with
diabetes in Nigeria [19], a precision of 5 % and a z value
of 1.96. Based on these assumptions a minimum of 370
participants was required.
Results
General characteristics of participants
We included 636 type 2 diabetic patients (53.1 % males)
aged 20 to 86 years (mean age 56.5 ± 10.6 years), with a
median known duration of diabetes of 4 years (25th–75th
percentiles, 1–9). Compared with males, females were
more likely to be overweight or obese (76.1 % vs. 70.1 %,
p = 0.042), had poorer diabetes control based on mean
HbA1c (8.5 % vs. 8.1 %, p = 0.046) and were less likely to
be current smokers (4.4 % vs. 15.9 %, p < 0.001) (Table 1).
Other baseline characteristics of the participants are
summarized in Table 1.
Prevalence and distribution of anemia
The mean hemoglobin (Hb) levels were 13.2 ± 2.0 g/dl in
males and 12.3 ± 1.5 g/dl in females (p < 0.001). Accord-
ing to the WHO criteria, 263 patients (41.4 %) had
anemia. The prevalence was 42.6 % in females (n = 127)
and 40.2 % in males (n = 136). Using the threshold rec-
ommended for intervention (Hb < 11 g/dl for both
sexes), 91 patients (14.3 %), including 48 females
(prevalence 16.1 %) and 43 males (prevalence 12.7 %),
had anemia.
The average mean corpuscular volume (MCV) in
the total population was 86.3 ± 7.7 fl. The difference
in the distribution of mean corpuscular volume cat-
egories between patients with anemia and those with-
out anemia was significant (p < 0.001), with anemic
patients having more microcytosis and macrocytosis
than non-anemic patients (Table 2). The average
MCHC was 32.4 ± 2.7 in the total population. Low
MCHC was more common in anemic than non-
anemic participants, 103 (47.3 %) and 100 (38.3 %)
respectively (p = 0.05) (Table 2).
Kidney function and anemia
Proteinuria was positive in 68.4 % (n = 180) of patients
with anemia as compared with 57.6 % (n = 215) of pa-
tients without anemia (p = 0.001). The mean eGFR of
the 584 patients (91.2 %) with eGFR data was 86.2 ±
31.7 ml/min/1.73 m2. Patients with anemia had lower
mean eGFR than patients without anemia (72.9 ± 35.7 vs.
89.6 ± 29.5 ml/min/1.73 m2, p < 0.001), and the Pearson
correlation coefficient between the eGFR and the
hemoglobin level was 0.29 (p < 0.001) (Fig. 1).
Two hundred and fifty (42.8 %) participants had nor-
mal kidney function (eGFR ≥90 ml/min/1.73 m2)
among whom 80 (31.9 %) were anemic compared with
160 (48.0 %) in patients with any CKD (p < 0.001). As
kidney function deteriorated, the prevalence of anemia
increased (Fig. 2). Compared with patients with normal
eGFR, patients with CKD (eGFR < 90 ml/min/1.73 m2)
of any degree were about two times more likely to have
anemia at levels where treatment was required.
Among the 108 (18.5 %) patients with chronic renal
failure (CRF) (eGFR < 60 ml/min/1.73 m2), 40 (37.0 %)
had anemia at levels requiring therapeutic intervention,
about four times higher than the 9.7 % in patients with-
out CRF (p < 0.001).
Other determinants of hemoglobin levels and anemia
Correlation coefficients between continuous variables
and hemoglobin levels are shown in Table 3. Age,
known duration of diabetes, systolic and diastolic blood
pressure levels and serum creatinine were inversely cor-
related with hemoglobin levels, while waist and hip cir-
cumference, fasting glucose, HbA1c, and triglycerides
were positively correlated with hemoglobin levels.
In multivariable logistic regressions, only eGFR [OR:
1.01 (95 % CI 1.00–1.02) per unit higher eGFR; p =
0.001] and the presence of diabetic retinopathy [OR:
2.32 (95 % CI 1.39–3.85); p = 0.023] were independent
determinants of anemia.
Feteh et al. BMC Nephrology  (2016) 17:29 Page 3 of 7
Discussion
In this study, we found that two in five patients with
type 2 diabetes had anemia. This high prevalence was
mainly driven by diabetes complications, as the presence
of retinopathy and declining kidney function were the
independent determinants of anemia. We also observed
that one third of diabetic patients with normal kidney
function had anemia.
Anemia is a common finding in patients with diabetes
and has a negative impact on the patient’s sense of well-
being; it also impairs the ability to work, reduces the
quality of life [20] and worsens cardiovascular health
[12]. The prevalence of anemia in our study (41.4 %) was
relatively higher than that reported in the general adult
population in Cameroon (34 %) [21]. The prevalence of
Table 2 Comparison of red cell parameters categories between





Normocytosis* (MCV 80–100 fl) 73.3 82.1
Microcytosis* (MCV < 80 fl) 21.4 15.1
Macrocytosis* (MCV > 100 fl) 5.4 2.9
Normochromia (MCHC 32–36 g/dl) 52.8 61.7
Hypochromia (MCHC < 32 g/dl) 47.3 38.3
aAnemia defined as hemoglobin concentration <12 g/dl for females and
<13 g/dl for males
*p value < 0.05
Table 1 General characteristics of participants
Variables Women (n = 298) Men (n = 338) p-value Total (n = 636)
Mean age (years) 57.6 ± 11.5 55.6 ± 9.7 0.190 56.5 ± 10.6
Smoking 13 (4.4) 53 (15.9) <0.001 66 (10.4)
Body mass index (kg/m2) 30.5 ± 6.6 28.2 ± 5.1 <0.001 29.3 ± 14.7
Overweight or obese (BMI≥ 25 kg/m2) 228 (76.5) 237 (70.1) 0.042 465 (73.3)
Obese (BMI≥ 30 kg/m2) 124 (44.6) 100 (32.1) 0.009 224 (38.4)
Waist circumference (cm) 97.3 ± 12.4 98.7 ± 12.9 0.167 98.0 ± 12.7
Hip circumference (cm) 108.4 ± 13.3 102.8 ± 10.7 <0.001 105.4 ± 12.3
Abdominal obesitya 252 (84.6) 198 (58.6) <0.001 450 (70.8)
Systolic blood pressure (mmHg) 136.2 ± 21.1 137.7 ± 22.4 0.339 137.0 ± 21.8
Diastolic blood pressure (mmHg) 82.4 ± 12 82.1 ± 12.6 0.764 82.3 ± 12.3
Hypertension 188 (63.3) 206 (61.0) 0.542 394 (62.2)
Any BP-lowering medication 168 (56.4) 184 (54.4) 0.576 352 (55.3)
ACEI/ARB 145 (48.7) 163 (48.2) 0.575 308 (48.4)
Diuretics 104 (34.9) 114 (33.7) 0.654 218 (34.3)
Calcium channel blockers 72 (24.2) 68 (20.1) 0.129 140 (22.0)
Beta blockers 7 (2.3) 6 (1.8) 0.410 13 (2.0)
Use of metformin 244 (81.9) 268 (79.3) 0.696 512 (80.5)
Use of sulfonylureas 172 (57.7) 192 (56.8) 0.585 364 (57.2)
Use of Acarbose 6 (2.0) 8 (2.4) 0.335 14 (2.2)
Use of Insulin 31 (10.4) 37 (10.9) 0.383 68 (10.7)
HbA1c (%) 8.5 ± 2.6 8.1 ± 2.5 0.046 8.6 ± 2.5
Fasting capillary glucose (mg/dl) 150 ± 60 140 ± 60 0.646 150 ± 60
Any diabetic retinopathy 52 (22.4) 83 (30.4) 0.080 135 (26.7)
Any diabetic nephropathy 83 (31.6) 128 (40.9) 0.020 211 (36.6)
Any diabetic neuropathy 141 (51.1) 165 (52.4) 0.821 306 (51.7)
Serum Creatinine (mg/dl) 0.93 ± 0.36 1.22 ± 0.58 <0.001 1.08 ± 0.47
eGFR (ml/min/1.73 m2) 86.2 ± 30.4 86.2 ± 32.0 ≥0.999 86.2 ± 31.7
Data are presented as number (%) or mean ± standard deviation;
Abbreviations: ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, BMI body mass index, BP blood pressure, eGFR estimated glomerular
filtration rate, HbA1c glycated hemoglobin
aAbdominal obesity: waist circumference >80 cm in females or >94 cm in males
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anemia in diabetic patients reported elsewhere is com-
parable to, or lower than our finding, depending on the
level of development of the country, the geographical
altitude and the age of the study population: 46.5 % in
Caribbean population [8], 17 % in Ethiopia [22] and 12
[6] to 23 % [7] in Caucasians. The higher altitude in
Ethiopia and their younger study population may ac-
count for the lower prevalence, whereas the high preva-
lence of infectious causes and nutritional deficiencies,
asymptomatic inherited hemoglobinopathies, and sub-
optimal glycemic control in our population could
explain the higher prevalence in the present study com-
pared with Caucasians [23]. The high prevalence of
microcytosis in our study suggests the importance of
non-renal causes of anemia in diabetes patients in this
setting. This may have implications on the manage-
ment options. However, further research is needed to
fully investigate the spectrum of the etiology of anemia
in African populations with diabetes.
In Cameroon, the prevalence CKD is about 13.2 % in
the adult population, with the rate being higher amongst
rural dwellers, and risk factors profile being similar to
Fig. 1 Correlation between the hemoglobin level and the estimated glomerular filtration rate. Squares represent individual hemoglobin levels of
participants. The red line is the linear regression line
Fig. 2 Prevalence of anemia by estimated glomerular filtration rate categories. Red bars represent anemia based on the World Health Organization
definition; blue bars represent anemia based on threshold for intervention. Numbers above the bars denote the prevalence of anemia in each
category of estimated glomerular filtration rate
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those in Caucasian populations [24]. In accordance with
previous studies [6–8, 10, 22, 25] our findings illustrate
the negative role of renal function decline in the devel-
opment and progression of anemia in patients with dia-
betes. However, the absence of overt kidney disease was
not protective against anemia, as 31.9 % of patients with
normal eGFR had anemia; this proportion is high when
compared with findings in other populations−13 % in
China [25]. This observation emphasizes the role of
other aforementioned contributors to anemia in diabetic
patients in Cameroon.
Our finding that retinopathy was a significant deter-
minant of anemia is in line with previous reports in
India [26]. This is probably because diabetes retinopathy
is usually associated with diabetes nephropathy. How-
ever, anemia may in turn play a pervasive role on the
microvascular complications [27]. Although HbA1c was
not an independent determinant of anemia, patients
with normal hemoglobin levels had significantly higher
level of HbA1c than anemic patients, as observed by
other authors [25]. This raises caution in interpreting
HbA1c levels in diabetic patients in Africa, as anemia
has also been shown to spuriously lower HbA1c [28].
We acknowledge the following potential limitations of
our study. Since it was conducted in a tertiary care hos-
pital, results may overestimate the actual burden of
anemia in diabetic patients in primary healthcare. Also
this study was not designed to identify the causes of
anemia in diabetic patients, indicating the need for fur-
ther research in this domain. The reticulocyte count and
the role of chronic inflammation on prevalent anemia
was not assessed, and the presence of hemoglobinopa-
thies was not investigated. However, we had a relatively
large sample size of routinely monitored type 2 diabetic
patients and we used robust statistical tests to identify
the determinants.
Conclusions
In conclusion, the prevalence of anemia in the type 2 dia-
betic population in Cameroon is high, including in pa-
tients with normal kidney function. However, declining
kidney function appears as the main determinant. Our
findings suggest that patients with diabetes should be rou-
tinely screened for anemia, and have other non-renal
causes checked. Further, the findings raise issues regarding
the added economic burden to diabetic patients attribut-
able to anemia, and the cautious interpretation of the
HbA1c level in sub-Saharan Africans.
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